Phase I/II Cabazitaxel for Recurrent Malignant Glioma

Summary

The goal of Part 1 of this clinical research study is to find the highest tolerable dose of cabazitaxel that can be given to patients with glioblastoma. The goal of Part 2 is to learn if cabazitaxel can help to control glioblastoma. The safety of the study drug will also be studied in both parts. Cabazitaxel is designed to interfere with the growth of cancer cells by stopping cell division.

Timeline

Start

2013-04

Primary completion

2017-04

Completion

—

Drugs

Indications